• Advertise
  • About us
  • Terms and Conditions
  • Contact us
Tuesday, August 11, 2026
Australian Times News
  • News
    • Weather
    • Sport
    • Technology
    • Business & Finance
      • Currency Zone
    • Lotto Results
      • The Lott
  • Lifestyle
    • Entertainment
    • Horoscopes
    • Health & Wellness
    • Recipes
  • Travel
  • Expat Life
  • Move to Australia
No Result
View All Result
  • News
    • Weather
    • Sport
    • Technology
    • Business & Finance
      • Currency Zone
    • Lotto Results
      • The Lott
  • Lifestyle
    • Entertainment
    • Horoscopes
    • Health & Wellness
    • Recipes
  • Travel
  • Expat Life
  • Move to Australia
No Result
View All Result
Australian Times News
No Result
View All Result
Home News

Australia secures 20-million extra AstraZeneca Covid-19 vaccines

New order will help to cover shortfall after promising vaccine trials at the University of Queensland had to be abandoned.

Mike Simpson by Mike Simpson
13-12-2020 03:00
in News
Image by Shutterbug75 from Pixabay

Image by Shutterbug75 from Pixabay

On the basis of scientific advice, the Australian Government says it has secured an additional 20-million doses of the promising AstraZeneca Covid-19 vaccine in order to strengthen the pursuit of a whole-of-population vaccination.

This will mean a total delivery of 53.8-million AstraZeneca vaccine doses in 2021, which would cover the entire population. The extra 20-million doses will be produced within the country by biotech firm CSL.

“Our advice remains that Australia remains on track for first vaccinations in March, and completion of whole of population in 2021,” Minister for Health, Greg Hunt, said.

Total of 51-million vaccines purchased

In addition, a further 11-million doses of the Novavax vaccine will be purchased, bringing the total for this vaccine to 51-million.  This provides an additional whole-of-population vaccine for Australia if proven safe and effective, Hunt stated.

A purchasing agreement is also in place for the Pfizer/BioNTech Covid-19 vaccine, with 10-million doses scheduled for early 2021.

The Australian Government is also part of the international COVAX Facility, which allows the purchases of over 25-million doses of a range of other potential vaccines.

University of Queensland trials abandoned

However, a statement by Hunt has confirmed that a promising Australian candidate for a coronavirus vaccine being trialled by CSL and the University of Queensland has been abandoned after trial participants returned false HIV-positive results.

AlsoRead...

Managing Aussie Share Portfolios Abroad: Tips for Growth

Managing Aussie Share Portfolios Abroad: Tips for Growth

2 July 2026
The New Meaning of Luxury: Lessons from Entrepreneur Chloe Hardy

The New Meaning of Luxury: Lessons from Entrepreneur Chloe Hardy

2 July 2026

The Federal government had previously agreed to buy 51-million doses of the vaccine. But the shortfall will now be filled by the vaccines being purchased elsewhere.

Both the university and CSL have emphasised that the positive results were false, meaning trial participants’ health was not at risk.

Not all eggs are in one vaccine basket

“As part of all clinical trials, assessments are made before expanding to the next phase of research,” Hunt explained.

“This decision is based on how the vaccine interacts with a testing system and has not been based on the safety or effectiveness of the [potential] vaccine.”

According to Hunt, Australia has deliberately not put all of its eggs in the one vaccine basket.

Tags: AstraZenecaCovid-19 in AustraliaCovid-19 vaccineUniversity of Queensland
DMCA.com Protection Status

SUBSCRIBE to our NEWSLETTER

[mc4wp_form id=”2384248″]

Don't Miss

Why Smarter Fleet Management Is For All Modern Business Options

by Fazila Olla-Logday
29 July 2026
Smarter Fleet Management
Motoring

Operating a business that relies on vehicles is harder than ever.

Read moreDetails

Animal Communication Goes Beyond What Science Can Currently Measure: Zoologist and Spiritual teacher Artemis, the heart whisperer on what the textbooks don’t teach

by Australian Times
7 July 2026
Animal Communication Goes Beyond What Science Can Currently Measure
Lifestyle

Animal communication classes and formal training can be valuable, providing tools, structure, and guidance.

Read moreDetails

Managing Aussie Share Portfolios Abroad: Tips for Growth

by Fazila Olla-Logday
2 July 2026
Managing Aussie Share Portfolios Abroad: Tips for Growth
at

Unlock the secrets to optimizing your Aussie share portfolios abroad. Discover essential tips for growth and navigate the global market...

Read moreDetails

The New Meaning of Luxury: Lessons from Entrepreneur Chloe Hardy

by Pauline Torongo
2 July 2026
The New Meaning of Luxury: Lessons from Entrepreneur Chloe Hardy
Business & Finance

Chloe Hardy, the founder and CEO of Dupes & Co established an Australian-made beauty brand focused on affordability and product...

Read moreDetails

Excel Funding Group emerges as Specialist in SMSF Property Lending amid growing demand

by Pauline Torongo
26 June 2026
Excel Funding Group emerges as Specialist in SMSF Property Lending amid growing demand
Business & Finance

Excel Funding Group has hit a new milestone, tripling its SMSF loan settlement volumes compared to Q1 2025.

Read moreDetails

Svitla Systems acquires Australia’s Kiandra IT to expand Global Engineering Footprint and Accelerate AI-Driven delivery

by Pauline Torongo
11 May 2026
Svitla Systems
Business & Finance

Acquisition marks Svitla’s entry into the Australian market and strengthens capabilities in low-code, Microsoft technologies, and enterprise software engineering.

Read moreDetails

Residential Healthcare Practices: Revolution or Evolution?

by Pauline Torongo
11 May 2026
Residential Healthcare Practices: Revolution or Evolution?
Lifestyle

President Bill Lutz’s "revolution" was born from his background in fine dining, which instilled a disciplined, customer-focused approach.

Read moreDetails
Load More

Copyright © Blue Sky Publications Ltd. All Rights Reserved.
australiantimes.co.uk is a division of Blue Sky Publications Ltd. Reproduction without permission prohibited. DMCA.com Protection Status

  • About us
  • Write for Us
  • Advertise
  • Contact us
  • T&Cs, Privacy and GDPR
No Result
View All Result
  • News
    • Weather
    • Sport
    • Technology
    • Business & Finance
      • Currency Zone
    • Lotto Results
      • The Lott
  • Lifestyle
    • Entertainment
    • Horoscopes
    • Health & Wellness
    • Recipes
  • Travel
  • Expat Life
  • Move to Australia

Copyright © Blue Sky Publications Ltd. All Rights Reserved.
australiantimes.co.uk is a division of Blue Sky Publications Ltd. Reproduction without permission prohibited. DMCA.com Protection Status

No Result
View All Result
  • News
    • Weather
    • Sport
    • Technology
    • Business & Finance
      • Currency Zone
    • Lotto Results
      • The Lott
  • Lifestyle
    • Entertainment
    • Horoscopes
    • Health & Wellness
    • Recipes
  • Travel
  • Expat Life
  • Move to Australia

Copyright © Blue Sky Publications Ltd. All Rights Reserved.
australiantimes.co.uk is a division of Blue Sky Publications Ltd. Reproduction without permission prohibited. DMCA.com Protection Status